Eli Lilly and Company LLY | NYSE

$797.37 -$10.21 | -1.26%

Company Overview:

Market Cap: $755.70B
PE Ratio: 64.88
52-Week Range: $677.09 - $972.53
Dividend Yield (FWD): 0.75% ($6.00)

10 Year LLY Performance Metrics:

Total Return (with DRIP): 1,048% (27.64% CAGR)
Total Return (no DRIP): 901% (25.90% CAGR)
Share Price: 861% (25.40% CAGR)
Dividend Increase: 200.0% (11.61% CAGR)
LLY 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

LLY Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
Share Price
LLY Price CAGR:1Y: -9.27%2Y: 33.92%5Y: 38.08%10Y: 25.40%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

LLY Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - LLY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - LLY
14-Day FREE Trial Get Full Access Now!

LLY Earnings, Revenue, Cash & Debt, Shares Outstaning:

LLY - Revenue
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 45.17%2Y: 35.23%5Y: 16.78%10Y: 10.61%
LLY - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
LLY EPS CAGR:1Y: 23.39%2Y: 43.31%5Y: 13.85%10Y: 19.86%
LLY - Net Income
14-Day FREE Trial Get Full Access Now!
LLY Net Income CAGR:1Y: 23.02%2Y: 43.24%5Y: 13.63%10Y: 17.95%
LLY - EBITDA
14-Day FREE Trial Get Full Access Now!
LLY EBITDA CAGR:1Y: 33.58%2Y: 56.30%5Y: 18.06%10Y: 12.75%
LLY - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow CAGR:1Y: -13.13%2Y: -56.56%5Y: 7.04%10Y: 8.83%
LLY - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow / Share CAGR:1Y: -12.93%2Y: -56.50%5Y: 7.26%10Y: 9.11%
LLY - Operating Income
14-Day FREE Trial Get Full Access Now!
LLY Operating Income CAGR:1Y: 106.47%2Y: 90.27%5Y: 27.73%10Y: 26.26%
LLY - Gross Profit
14-Day FREE Trial Get Full Access Now!
LLY Gross Profit CAGR:1Y: 45.22%2Y: 40.34%5Y: 17.73%10Y: 11.77%
LLY - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
LLY Shares Outstanding CAGR:1Y: -0.35%2Y: -0.15%5Y: -0.24%10Y: -1.68%
LLY - Share Buybacks
14-Day FREE Trial Get Full Access Now!
LLY Share Buybacks CAGR:1Y: 0.00%2Y: 26.49%5Y: 19.14%10Y: 14.47%
LLY - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
LLY Stock-Based Comp CAGR:1Y: -3.58%2Y: 8.24%5Y: 16.44%10Y: 12.13%
LLY - Expenses
14-Day FREE Trial Get Full Access Now!
LLY Expenses CAGR:1Y: 53.05%2Y: 29.26%5Y: 40.95%10Y: 14.53%
LLY - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
LLY - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
LLY - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
LLY - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
LLY - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
LLY - Cash & Debt
14-Day FREE Trial Get Full Access Now!
LLY - Dividends
14-Day FREE Trial Get Full Access Now!
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
LLY - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 45.17%2Y: 35.23%5Y: 16.78%10Y: 10.61%
LLY - Revenue by Region
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 45.17%2Y: 35.23%5Y: 16.78%10Y: 10.61%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

LLY - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual Revenue CAGR:1Y: 45.17%2Y: 35.23%5Y: 16.78%10Y: 10.61%
LLY - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual EPS CAGR:1Y: 23.39%2Y: 43.31%5Y: 13.85%10Y: 19.86%
LLY - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual Net Income CAGR:1Y: 23.02%2Y: 43.24%5Y: 13.63%10Y: 17.95%
LLY - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual EBITDA CAGR:1Y: 33.58%2Y: 56.30%5Y: 18.06%10Y: 12.75%

Ratios, Profit Margins & Return on Capital:

LLY - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
LLY Net Profit Margin CAGR:1Y: -15.25%2Y: 5.93%5Y: -2.70%10Y: 6.64%
LLY - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
LLY Gross Profit Margin CAGR:1Y: 0.04%2Y: 3.78%5Y: 0.81%10Y: 1.05%
LLY - Price to Earnings
14-Day FREE Trial Get Full Access Now!
LLY - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
LLY - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
LLY - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!
Compare stocks side-by-side
 

LLY Dividends Info:

Annual Dividend: $6
Forward Yield: 0.75%
Ex-Dividend Date: 2025-05-16
Lifetime Dividends / Share: $67.75

LLY Dividend History: Dates, Payments & Yield list

Below is a schedule of all LLY dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
05/16/202506/10/2025$1.5000.74%0.74%$807.19
02/14/202503/10/2025$1.5000.64%0.72%$829.76
11/15/202412/10/2024$1.3000.7%0.65%$799.58
08/15/202409/10/2024$1.3000.54%0.58%$901.25
05/15/202406/10/2024$1.3000.62%0.6%$865.00
02/14/202403/08/2024$1.3000.62%0.68%$762.14
11/14/202312/08/2023$1.1300.74%0.76%$598.05
08/14/202309/08/2023$1.1300.81%0.77%$586.46
05/12/202306/09/2023$1.1300.97%1.01%$446.04
02/14/202303/10/2023$1.1301.17%1.43%$315.02
11/14/202212/09/2022$0.9801.1%1.09%$360.99
08/12/202209/09/2022$0.9801.23%1.23%$317.70
05/13/202206/10/2022$0.9801.26%1.32%$297.01
02/14/202203/10/2022$0.9801.5%1.47%$266.02
11/12/202112/10/2021$0.8501.31%1.39%$244.14
08/12/202109/10/2021$0.8501.25%1.42%$239.50
05/13/202106/10/2021$0.8501.63%1.46%$233.54
02/11/202103/10/2021$0.8501.52%1.65%$205.45
11/12/202012/10/2020$0.7402.1%1.84%$161.00
08/13/202009/10/2020$0.7401.9%2.02%$146.22
05/14/202006/10/2020$0.7401.75%1.96%$151.00
02/13/202003/10/2020$0.7401.89%2.1%$141.19
11/14/201912/10/2019$0.6452.32%2.14%$120.65
08/14/201909/10/2019$0.6452.26%2.32%$111.10
05/16/201906/10/2019$0.6452.07%2.26%$113.93
02/14/201903/08/2019$0.6451.93%2.04%$126.70
11/14/201812/10/2018$0.5632.05%1.97%$114.09
08/14/201809/10/2018$0.5632.15%2.11%$106.42
05/16/201806/08/2018$0.5632.67%2.61%$86.08
02/14/201803/09/2018$0.5632.76%2.83%$79.61
11/14/201712/08/2017$0.5202.52%2.41%$86.45
08/11/201709/08/2017$0.5202.55%2.51%$82.92
05/11/201706/09/2017$0.5202.57%2.57%$81.04
02/13/201703/10/2017$0.5202.64%2.47%$84.36
11/10/201612/09/2016$0.5102.6%3.01%$67.85
08/11/201609/09/2016$0.5102.52%2.61%$78.24
05/11/201606/10/2016$0.5102.65%2.76%$73.95
02/10/201603/10/2016$0.5102.75%2.79%$73.02
11/10/201512/10/2015$0.5002.5%2.36%$84.91
08/12/201509/10/2015$0.5002.39%2.47%$80.84
05/14/201506/10/2015$0.5002.71%2.4%$83.18
02/11/201503/10/2015$0.5002.82%2.91%$68.78
11/12/201412/10/2014$0.4902.91%2.76%$71.05
08/13/201409/10/2014$0.4903.23%3.03%$64.78
05/13/201406/10/2014$0.4903.26%3.28%$59.75
02/12/201403/10/2014$0.4903.68%3.33%$58.90
11/13/201312/10/2013$0.4903.88%3.88%$50.49
08/13/201309/10/2013$0.4903.57%3.71%$52.87
05/14/201306/10/2013$0.4903.51%3.72%$52.64
02/13/201303/08/2013$0.4903.67%3.55%$55.16
11/13/201212/10/2012$0.4904.16%3.91%$50.12
08/13/201209/10/2012$0.4904.58%4.21%$46.52
05/11/201206/08/2012$0.4904.75%4.72%$41.53
02/13/201203/09/2012$0.4905.05%4.95%$39.56
11/10/201112/09/2011$0.4905.26%4.99%$39.27
08/11/201109/09/2011$0.4905.55%5.42%$36.13
05/11/201106/10/2011$0.4905.12%5.29%$37.05
02/11/201103/10/2011$0.4905.68%5.64%$34.77
11/10/201012/10/2010$0.4905.6%5.6%$34.98
08/11/201009/10/2010$0.4905.34%5.53%$35.43
05/12/201006/10/2010$0.4905.64%5.86%$33.46
02/10/201003/10/2010$0.4905.74%5.55%$35.34
11/10/200912/10/2009$0.4905.56%5.6%$35.02
08/12/200909/10/2009$0.4905.89%5.97%$32.82
05/13/200906/10/2009$0.4905.46%5.78%$33.91
02/11/200903/10/2009$0.4905.17%6.59%$29.72
11/12/200812/10/2008$0.4705.88%5.37%$35.01
08/13/200809/10/2008$0.4703.79%4.02%$46.73
05/13/200806/10/2008$0.4703.76%3.92%$47.94
02/13/200803/10/2008$0.4703.47%3.8%$49.42
11/13/200712/10/2007$0.4253.23%3.1%$54.78
08/13/200709/10/2007$0.4252.94%3.03%$56.14
05/11/200706/08/2007$0.4252.82%2.98%$57.02
02/13/200703/09/2007$0.4252.99%3.23%$52.59
11/13/200612/08/2006$0.4002.96%2.96%$54.00
08/11/200609/08/2006$0.4002.91%2.9%$55.26
05/11/200606/09/2006$0.4003.05%3.09%$51.74
02/13/200603/10/2006$0.4002.78%2.79%$57.25
11/10/200512/09/2005$0.3802.96%2.85%$53.41
08/11/200509/09/2005$0.3802.79%2.68%$56.72
05/11/200506/10/2005$0.3802.5%2.67%$56.99
02/11/200503/10/2005$0.3802.6%2.74%$55.56
11/10/200412/10/2004$0.3552.55%2.58%$55.04
08/11/200409/10/2004$0.3552.24%2.16%$65.85
05/12/200406/10/2004$0.3551.87%1.93%$73.64
02/11/200403/10/2004$0.3551.82%2.01%$70.49
11/12/200312/10/2003$0.3352.02%1.9%$70.40
08/13/200309/10/2003$0.3352.11%2.16%$62.03
05/13/200306/10/2003$0.3352.02%2.22%$60.23
02/12/200303/10/2003$0.3352.15%2.39%$56.00
11/13/200212/10/2002$0.3102.06%1.88%$66.10
08/13/200209/10/2002$0.3102.16%2.14%$57.81
05/13/200206/10/2002$0.3101.83%2.02%$61.31
02/13/200203/08/2002$0.3101.51%1.59%$78.20
11/13/200112/10/2001$0.2801.42%1.37%$81.54
08/13/200109/10/2001$0.2801.4%1.45%$77.20
05/11/200106/11/2001$0.2801.29%1.29%$87.00
02/13/200103/09/2001$0.2801.33%1.42%$79.00
11/13/200012/11/2000$0.2601.21%1.12%$92.88
08/11/200009/11/2000$0.2601.31%1.48%$70.25
05/11/200006/09/2000$0.2601.31%1.37%$76.19
02/11/200003/10/2000$0.2601.54%1.7%$61.19
11/10/199912/10/1999$0.2301.21%1.4%$65.88
08/11/199909/10/1999$0.2301.45%1.27%$72.38
05/12/199906/10/1999$0.2301.13%1.3%$70.69
02/10/199903/10/1999$0.2300.95%1%$91.81
11/10/199812/10/1998$0.2000.93%0.92%$86.81
08/12/199809/10/1998$0.2001.17%1.1%$72.81
05/13/199806/10/1998$0.2001.14%1.26%$63.38
02/11/199803/10/1998$0.2001.15%1.2%$66.44
11/12/199712/10/1997$0.2001.17%1.26%$63.31
08/13/199709/10/1997$0.1801.36%1.37%$52.59
05/13/199706/10/1997$0.1801.51%1.44%$50.00
02/12/199703/10/1997$0.1801.53%1.57%$45.75
11/13/199612/10/1996$0.1711.81%1.83%$37.44
08/13/199609/10/1996$0.1712.32%2.31%$29.63
05/13/199606/10/1996$0.1712.42%2.06%$33.31
02/13/199603/11/1996$0.1712.07%2.14%$32.00
11/13/199512/11/1995$0.1712.72%2.7%$25.41
08/11/199509/11/1995$0.1613.37%3.1%$20.81
05/09/199506/12/1995$0.1613.47%3.39%$19.00
02/09/199503/10/1995$0.1613.84%3.79%$17.03
11/08/199412/12/1994$0.1563.96%3.99%$15.66
08/09/199409/12/1994$0.1565.09%4.44%$14.09
05/09/199406/10/1994$0.1564.63%4.38%$14.28
02/09/199403/10/1994$0.1564.22%4.8%$13.03
11/08/199312/10/1993$0.1514.34%4.23%$14.31
08/09/199309/10/1993$0.1515.33%5.02%$12.06
05/10/199306/10/1993$0.1514.55%4.89%$12.38
02/09/199303/10/1993$0.1514.15%4.55%$13.31
11/06/199212/10/1992$0.1383.59%3.37%$16.31
08/10/199209/10/1992$0.1383.08%3.29%$16.72
05/11/199206/10/1992$0.1383.12%3.4%$16.16
02/10/199203/10/1992$0.1382.59%3.05%$18.06
11/08/199112/10/1991$0.1252.63%2.7%$18.53
08/09/199109/10/1991$0.1252.41%2.49%$20.06
05/09/199106/10/1991$0.1252.36%2.62%$19.09
02/07/199103/11/1991$0.1252.34%2.4%$20.81
11/08/199012/10/1990$0.1032.39%2.15%$19.06
08/09/199009/10/1990$0.1032.01%2.18%$18.81
05/09/199006/11/1990$0.1032.17%2.14%$19.19
02/09/199003/12/1990$0.1032.26%2.6%$15.75
11/09/198912/11/1989$0.0842.11%2.09%$16.16
08/09/198909/11/1989$0.0842.12%2.23%$15.09
05/09/198906/12/1989$0.0842.37%2.37%$14.19
02/09/198903/10/1989$0.0842.53%2.73%$12.38
11/08/198812/12/1988$0.0722.64%2.62%$10.98
08/09/198809/12/1988$0.0722.67%2.66%$10.81
05/09/198806/10/1988$0.0722.78%2.73%$10.53
02/09/198803/10/1988$0.0722.84%2.96%$9.70
11/06/198712/10/1987$0.0632.65%2.92%$8.56
08/10/198709/10/1987$0.0631.97%2.12%$11.78
05/11/198706/10/1987$0.0632.19%2.13%$11.75
02/09/198703/10/1987$0.0632.18%2.04%$12.25
11/07/198611/12/1986$0.0562.41%2.37%$9.50
08/11/198608/13/1986$0.0562.3%2.26%$9.94
05/09/198605/14/1986$0.0562.41%2.63%$8.56
02/10/198602/12/1986$0.0562.95%3.21%$7.02
11/08/198511/13/1985$0.0503.36%3.22%$6.22
08/09/198508/14/1985$0.0503.85%3.77%$5.31
05/09/198505/13/1985$0.0503.97%4.07%$4.91
02/08/198502/13/1985$0.0504.19%4.36%$4.59
11/08/198411/12/1984$0.0504.73%5.1%$3.92
08/09/198408/13/1984$0.0454.97%5.05%$3.59
05/09/198405/11/1984$0.0454.66%4.64%$3.91
02/08/198402/10/1984$0.0454.6%4.67%$3.88
11/07/198311/09/1983$0.0450%4.8%$3.78
08/09/198308/11/1983$0.0450%4.8%$3.78
05/09/198305/11/1983$0.0410%4.3%$3.78
02/09/198302/11/1983$0.0410%4.3%$3.78
11/05/198211/10/1982$0.0410%4.3%$3.78
08/09/198208/11/1982$0.0410%4.3%$3.78
05/10/198205/12/1982$0.0410%4.3%$3.78
02/08/198202/10/1982$0.0410%4.3%$3.78
11/06/198111/11/1981$0.0360%3.8%$3.78
08/10/198108/12/1981$0.0360%3.8%$3.78
05/11/198105/13/1981$0.0360%3.8%$3.78
02/05/198102/09/1981$0.0360%3.8%$3.78
11/07/198011/12/1980$0.0360%3.8%$3.78
08/11/198008/13/1980$0.0360%3.8%$3.78
05/12/198005/14/1980$0.0330%3.47%$3.78
02/08/198002/13/1980$0.0330%3.47%$3.78
11/02/197911/07/1979$0.0330%3.47%$3.78
08/06/197908/08/1979$0.0330%3.47%$3.78
05/07/197905/09/1979$0.0280%2.98%$3.78
02/05/197902/07/1979$0.0280%2.98%$3.78
11/03/197811/08/1978$0.0280%2.98%$3.78
08/07/197808/09/1978$0.0250%2.65%$3.78
05/08/197805/10/1978$0.0250%2.65%$3.78
02/06/197802/08/1978$0.0250%2.65%$3.78
11/03/197711/07/1977$0.0220%2.35%$3.78
08/08/197708/10/1977$0.0220%2.35%$3.78
05/09/197705/11/1977$0.0220%2.35%$3.78
02/04/197702/09/1977$0.0220%2.35%$3.78
11/05/197611/10/1976$0.0200%2.15%$3.78
08/09/197608/11/1976$0.0200%2.15%$3.78
05/10/197605/12/1976$0.0190%1.98%$3.78
02/06/197602/11/1976$0.0190%1.98%$3.78
11/07/197511/12/1975$0.0170%1.82%$3.78
08/11/197508/13/1975$0.0170%1.82%$3.78
05/12/197505/14/1975$0.0170%1.82%$3.78
02/07/197502/12/1975$0.0170%1.82%$3.78
11/08/197411/13/1974$0.0160%1.65%$3.78
08/12/197408/14/1974$0.0160%1.65%$3.78
05/13/197405/15/1974$0.0150%1.55%$3.78
02/08/197402/13/1974$0.0150%1.55%$3.78
11/12/197311/14/1973$0.0130%1.37%$3.78
08/13/197308/15/1973$0.0130%1.37%$3.78
05/14/197305/16/1973$0.0120%1.25%$3.78
02/09/197302/14/1973$0.0120%1.25%$3.78
11/13/197211/15/1972$0.0110%1.2%$3.78
08/07/197208/09/1972$0.0110%1.2%$3.78

Projected Future Returns & Dividends for LLY

Based on past 10-year performance, here are LLY growth metrics:

Share price CAGR of +25.4%
Dividend CAGR of +11.61%

Using LLY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

LLY (DRIP)LLY - No DRIP
Current Price$803.00$803.00
Start Shares12.4512.45
Start Value$10,000$10,000
  
After 10 years:
Final Share Count13.0512.45
Dividends Payment$4.50$4.50
Annual Dividends$235$224
Yield on cost2.35%2.24%
Share Price$6,156.04$6,156.04
Total Dividends$1,328$1,287
Final Value$80,330$77,950

Estimated Future Value + Dividends - LLY

NOTE: Above numbers are our estimate based on LLY's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Eli Lilly and Company (LLY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

LLY website: https://www.lilly.com

Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial